Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0760
+0.0010 (1.33%)
May 8, 2026, 3:44 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 91.87 million as of May 8, 2026. Its market cap has decreased by -18.32% in one year.
Market Cap
91.87M
Enterprise Value
72.50M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 91.87M, an increase of 419.76%. That is a compound annual growth rate of 7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 91.87M | -17.76% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nyrada | 137.17M |
| Dimerix | 129.09M |
| Alterity Therapeutics | 119.63M |
| Island Pharmaceuticals | 104.31M |
| Paradigm Biopharmaceuticals | 97.21M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |
| LTR Pharma | 79.07M |